Cancer Identified as a New Cardiovascular Risk Factor A history of cancer is an independent predictor of major cardiovascular events in patients undergoing coronary angioplasty. Cancer should be considered a new cardiovascular risk factor in primary and secondary prevention.

Management of arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. Treating this condition can be challenging due to progressive fibrosis, phenotypic variations and small patient cohorts limiting the feasibility of conducting meaningful clinical trials.

New AHA Statement on Ischemia After Cardiac Surgery The American Heart Association (AHA) outlines "considerations" on the management of acute postoperative myocardial ischemia (PMI) after cardiac surgery in a scientific statement.

New ESH Hypertension Guidelines Aim for Simplified Message The European Society of Hypertension (ESH) has released updated and expanded guidelines for the management of hypertension.

The international activities of the Cardioprogress Foundation are expanding The Cardioprogress Foundation expands its international activities. A register of 7 thousand experts and an opinion of leaders from 46 countries of the world has been created.

Innovative technologies in medicine. International Congress DATS 2023 (Baku, Azerbaijan) From June 17 to June 22, 2023, the International Congress DATS 2023 was held in the capital of Azerbaijan in Baku, organized by the Tabib (State Administration for Medical Territorial Services of Azerbaijan).

WHO Advises Against Nonsugar Sweeteners for Weight Control A new guideline from the World Health Organization (WHO) on nonsugar sweeteners (NSSs) recommends not using them to control weight or reduce the risk for diabetes, heart disease, or cancer. These sweeteners include aspartame, acesulfame K, advantame, saccharine, sucralose, stevia, and stevia derivatives.

Keynote presentation «T2DM and Coronary Heart Disease». Prof Mamedov Mekhman On May 24-25, 2023, the anniversary International Heart Congress in a hybrid regime was held in Tokyo (Japan). Speakers from 25 countries of the world took part in the scientific program. The key presentation by Professor Mekhman Mamedov (Moscow, Russia) was devoted to the features of coronary artery revascularization and life prognosis in patients with diabetes mellitus and coronary heart disease. The lecture covered issues on the prevalence of diabetes in the world, the relationship with cardiovascular diseases and the prevention of complications.

European Associations Review Dietary Therapies for Obesity The European Association for the Study of Obesity (EASO) and the European Federation of the Associations of Dietitians (EFAD) have published a position statement to provide an update on evidence-based options for the medical nutrition therapy of obesity. The statement is intended for health professionals and policymakers.

Expert Discusses Which Diets Are Best, Based on the Evidence Primary care providers can draw from a wide range of diets to give patients evidence-based advice on how to lose weight, prevent diabetes, and achieve other health goals, according to a speaker at the annual meeting of the American College of Physicians (San Diego).